Prosthetics isn't a big enough market to spur innovation for profit, so one amputee Iraq veteran is adapting the open source concept by reverse-engineering expired patents and posting them online. Hillary Wicai reports.
Pharmaceutical firms lose billions to companies that make generic versions of their drugs once patents expire. But the big problem is that they're running out of new meds to replace top sellers as that happens, Janet Babin reports.
The FDA is trying to protect the food supply of a nation that imports more than ever with a budget that hasn't kept pace with inflation. Today lawmakers take a critical look at the situation, Jeremy Hobson reports.
Some of us pay for special pampering on our days off — maybe a massage or some other treat. But there are companies trying to de-stress workers right at their desks. Cash Peters reports.
The FDA's still trying to sort out last month's pet food scare. It thinks it's tracked the offending chemical back to China, where the government seems to be genuinely invested in helping. But it won't be easy, Scott Tong tells us.
A new survey finds nearly all physicians report some type of relationship with the pharmaceutical industry — everything from getting free food to "professional services." Bob Moon reports.
The FDA is looking into whether melamine, a chemical usually found in plastics, might have found its way into the human food chain. Kai Ryssdal talked with market researcher Harry Balzer about how concerned we should be.
From peanut butter to bagged spinach to pet food, it hasn't exactly been the best year for the nation's food supply. That's led to calls for greater regulation, and Congress is poised to take action.
The giant pharmaceutical company, maker of the Crestor cholesterol drug, will pay $15.5 billion for MedImmune. Analysts say it's a good move, but the price may be too high. Helen Palmer reports.
A report by Social Security and Medicare trustees today triggered a funding warning — so President Bush will have to propose Medicare cuts to Congress next year. Jeremy Hobson reports.
